Lindsey Rolfe, See Remarks at Clovis Oncology, Inc. (CLVS), sold 2,545 shares at $1.20 ($3K) on 2022-09-02, disclosed to the SEC on 2022-09-06.
Seasonal sale ($3k) by See Remarks — this insider has traded CLVS in September in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| Filing → |
| CLVS | SELL | 2022-06-03 | $2K | — | Filing → |
| CLVS | SELL | 2022-05-03 | $8K | — | Filing → |
| CLVS | SELL | 2022-03-03 | $20K | — | Filing → |